Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

GE Healthcare Life Sciences and Osaka University Team Up

Published: Wednesday, August 21, 2013
Last Updated: Wednesday, August 21, 2013
Bookmark and Share
Top four graduate students to be hosted at GE Healthcare Life Science’s Uppsala site.

GE Healthcare Life Sciences has announced a joint program with Osaka University to offer students access to GE Healthcare’s cutting-edge expertise in training and technologies for biopharmaceutical research and manufacturing, to help support future growth of the sector in Japan.

The program, Interdisciplinary Program for Biomedical Sciences (IPBS), is Osaka University’s government-funded commitment to graduate education, which aligns with GE Healthcare Japan’s “Life Sciences Academy,” a GE Healthcare initiative launched in April 2013 with the objective of supporting the development of life sciences researchers in Japan.

Of the 14 IPBS graduate students, four will visit GE Healthcare Life Science’s Uppsala site for three weeks from 19 August to 6 September 2013.

While at GE Healthcare in Uppsala, the Osaka University students will experience day-to-day life in an R&D laboratory, closely working with GE Healthcare scientists and engineers.

The students will receive comprehensive training in GE Healthcare’s advanced bioprocessing technologies and gain first-hand experience of protein interaction analysis and laboratory-scale protein purification using GE Healthcare instruments including Biacore™ and MicroCal™ systems for label-free analyses and ÄKTA™ pure chromatography systems.

Anders Fält, Head of R&D, Bio-Analysis Systems, GE Healthcare Life Sciences, commented, “This joint program with Osaka University is a great way to share our knowledge and expertise, as well as encourage and inspire the life sciences researchers and manufacturing professionals of tomorrow. Specifically, we’re providing an opportunity for students from one of the leading Japanese universities to be introduced to the latest technologies and workflows from GE Healthcare, taking them closer to becoming tomorrow’s leading life scientists.”

Kiyoshi Takeda, MD, PhD, the coordinator of the Interdisciplinary Program for Biomedical Sciences (IPBS) at Osaka University, commented, “Our program seeks to educate young life scientists so that they will play an active role at the front lines of global-scale research collaborations whether it would be in the industry, academic or government sectors, during their careers. We strongly believe our students will gain valuable experience from the internship at the GE Healthcare Life Sciences R&D Center in Uppsala. Our joint program with GE Healthcare is an excellent example of cooperation between university and industry, a collaboration that has not been possible in the traditional Japanese education system. We hope such a collaborative educational program will strengthen the relations between academia and industry for the coming generations, leading the way to advanced treatment research for intractable diseases.”

During their visit, on which they will be joined by their Professor, Masayuki Miyasaka, a world-renowned immunologist, the students will also meet scientists at the SciLifeLab at the Karolinska Institutet, one of the largest medical universities in Europe.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GE Healthcare Life Sciences and Emerson Team Up
Collaboration will help drive improvements in productivity.
Saturday, November 28, 2015
GE Healthcare Life Sciences to Open Biopharmaceutical Technology and Training Laboratory in Turkey
Supports Turkey’s ambitions to expand domestic biopharmaceutical industry. Laboratory will be a key component of GE’s new Innovation Center in Istanbul.
Friday, November 14, 2014
GE Healthcare Life Sciences Named as Finalist for Four Bioprocess Industry Awards
Awards celebrate and recognize the outstanding people, organizations and technologies.
Saturday, October 04, 2014
GE Healthcare Life Sciences to Create New US Headquarters
When fully operational, the new facility will house more than 500 highly skilled employees and bring more than 220 new jobs to Massachusetts.
Wednesday, August 20, 2014
GE Healthcare Appoints Emmanuel Ligner as General Manager
Emmanuel will oversee all worldwide commercial activities of Company's rapidly growing BioProcess business.
Friday, April 11, 2014
GE, NetBio to Validate Fully Integrated Rapid DNA system
Verification by forensic laboratories is a key step toward responsible adoption for crime laboratory and in-the-field law enforcement use.
Friday, March 21, 2014
Spectacular Images Showing Research into Cancer, Neurodegenerative Disease and Fertility
Vanessa Auld from Canada, Martin Barr from Ireland and Graham Wright from Singapore announced as the winners of the GE Healthcare 2013 Cell Imaging Competition.
Wednesday, March 12, 2014
GE Healthcare to Build KUBio Factory for JHL Biotech in China
New factory to give JHL Biotech commercial biopharmaceutical manufacturing capabilities in Asia.
Thursday, September 26, 2013
GE Healthcare Life Sciences Completes Acquisition of Xcellerex, Inc.
Acquisition expands GE Healthcare’s offering of technologies and services for the manufacture of recombinant proteins, antibodies and vaccines.
Tuesday, May 15, 2012
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Revolutionary Technologies Developed to Improve Outcomes for Lung Cancer Patients
Breath test to detect lung cancer brings oxygen directly to the wound.
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
A Cellular Symphony Responsible for Autoimmune Disease
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Editing of LIMS Data Made Faster and More Efficient in Matrix Gemini
The latest version of the Matrix Gemini LIMS (Laboratory Information Management System) from Autoscribe Informatics now provides faster and more efficient editing of LIMS data by eliminating the need for a second editing screen.
University of Edinburgh, Selcia Achieve Key Milestones in Drug Development Program
Scientists from the University of Edinburgh, working with Selcia, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness.
Red Clover Genome to Help Restore Sustainable Farming
The Genome Analysis Centre (TGAC) in collaboration with IBERS, has sequenced and assembled the DNA of red clover to help breeders improve the beneficial traits of this important forage crop.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos